Literature DB >> 20136860

Perventricular closure of a large ventricular septal defect in congenitally corrected transposition of the great arteries.

Jamil Aboulhosn1, Dan Levi, Michael Sopher, Allen Johnson, John S Child, Hillel Laks.   

Abstract

We report the case of a 30 year-old male with congenitally corrected transposition of the great arteries, atrial, and ventricular septal defects (VSD), and pulmonary stenosis. He previously underwent three palliative surgical procedures before undergoing intracardiac repair at age 20 with a left ventricular to pulmonary artery (LV-PA) conduit, VSD closure, and replacement of the systemic atrioventricular valve. A residual VSD was noted postoperatively. He did well for approximately 10 years when he started becoming more breathless with daily activities and was noted to have a resting room air oxygen saturation of 85%. Despite increased diuretic therapy he continued to deteriorate and was ultimately admitted to the hospital in florid right and left heart failure with recurrent atrial fibrillation. Catheterization revealed pulmonary hypertension (pulmonary artery pressure = 80/17 mm Hg), moderate conduit stenosis, severe pulmonic regurgitation, and oxygen saturation of 75%. Calculated shunt fraction (Qp : Qs) was 1.3:1. He was referred for surgical intervention, specifically, LV-PA conduit replacement, oversewing of the pulmonic valve, VSD closure, and pacemaker placement. Intraoperatively, the VSD could not be closed despite multiple attempts through various approaches. Therefore, perventricular VSD closure using two Amplatzer septal occluders (AGA Medical, Golden Valley, MN) was performed in the operating room with the chest open off cardiopulmonary bypass. Following deployment, the residual shunt was small and the inferior vena cava-to-pulmonary artery saturation step-up was only 4%. The left ventricular systolic pressure decreased to one half systemic. This case highlights the utility and efficacy of a hybrid approach in the treatment of complex congenital heart disease.

Entities:  

Mesh:

Year:  2010        PMID: 20136860     DOI: 10.1111/j.1747-0803.2009.00339.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  2 in total

1.  Minimally-invasive-perventricular-device-occlusion versus surgical-closure for treating perimembranous-ventricular-septal-defect: 3-year outcomes of a multicenter randomized clinical trial.

Authors:  Wenxin Lu; Fengwen Zhang; Taibing Fan; Tianli Zhao; Yu Han; Xiaopeng Hu; Qi Li; Hao Shi; Xiangbin Pan
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

2.  Perventricular device closure of a large residual perimembranous interventricular septal defect after previous surgical correction.

Authors:  Edvin Prifti; Arben Baboci; Edvin Dado; Efrosina Kajo
Journal:  J Cardiothorac Surg       Date:  2014-01-10       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.